Return to site

Are your clinical and commercial strategies aligned?

A leading European VC [3/15 MedTech Strategist, p. 23] commented recently that "...you have to invest under the assumption that you will not find new investors for your companies...." A slew of attractive companies exist for investors, but "many are financed on a shoestring; they are just hanging on."
How does an early stage medical device company shepherd its resources by making cost effective, but measurable progress toward toward both its product development and commercial goals?  The BLG Group has found that a carefully crafted clinical program is critical.
All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly